AVN 59.93 Decreased By ▼ -0.36 (-0.6%)
BOP 10.15 Decreased By ▼ -0.01 (-0.1%)
CHCC 129.25 Increased By ▲ 0.10 (0.08%)
DCL 9.36 Increased By ▲ 0.01 (0.11%)
DGKC 107.39 Increased By ▲ 1.72 (1.63%)
EFERT 67.69 Decreased By ▼ -0.51 (-0.75%)
EPCL 32.90 Increased By ▲ 2.38 (7.8%)
FCCL 20.75 Decreased By ▼ -0.53 (-2.49%)
FFL 13.00 Decreased By ▼ -0.14 (-1.07%)
HASCOL 16.39 Increased By ▲ 0.55 (3.47%)
HBL 129.44 Increased By ▲ 1.44 (1.13%)
HUBC 88.68 Increased By ▲ 1.94 (2.24%)
HUMNL 9.00 Decreased By ▼ -0.37 (-3.95%)
JSCL 16.72 Decreased By ▼ -0.26 (-1.53%)
KAPCO 28.41 Increased By ▲ 0.63 (2.27%)
KEL 3.84 Decreased By ▼ -0.01 (-0.26%)
LOTCHEM 13.10 Increased By ▲ 0.20 (1.55%)
MLCF 35.87 Increased By ▲ 0.25 (0.7%)
OGDC 114.90 Increased By ▲ 0.19 (0.17%)
PAEL 34.71 Decreased By ▼ -0.44 (-1.25%)
PIBTL 12.00 Decreased By ▼ -0.16 (-1.32%)
PIOC 91.20 Increased By ▲ 3.30 (3.75%)
POWER 8.61 Decreased By ▼ -0.29 (-3.26%)
PPL 103.14 Increased By ▲ 1.38 (1.36%)
PSO 185.98 Decreased By ▼ -1.62 (-0.86%)
SNGP 57.33 Increased By ▲ 0.23 (0.4%)
STPL 11.80 Decreased By ▼ -0.02 (-0.17%)
TRG 50.06 Increased By ▲ 1.05 (2.14%)
UNITY 12.97 Decreased By ▼ -0.27 (-2.04%)
WTL 1.23 Decreased By ▼ -0.09 (-6.82%)
BR100 4,222 Decreased By ▼ -8 (-0.19%)
BR30 21,743 Decreased By ▼ -76 (-0.35%)
KSE100 40,473 Decreased By ▼ -86 (-0.21%)
KSE30 17,626 Increased By ▲ 19 (0.11%)
COVID-19 TOTAL DAILY
CASES 285,921 730
DEATHS 6,129 17
Sindh 124,556 Cases
Punjab 94,715 Cases
Balochistan 11,956 Cases
Islamabad 15,296 Cases
KP 34,859 Cases

(Karachi) UK neurologists have warned that coronavirus patients suffering mild symptoms or those recovering from the disease might experience potentially deadly brain disorder.

Publishing the paper in the journal Brain on Wednesday, neurologists said that there is an increase in a life-threatening condition called acute disseminated encephalomyelitis (Adem) during the first wave of infections in Britain.

Coronavirus vaccine to enter late-stage trial by July end: Researchers

As part of the research, British neurologists examined and analyzed 43 Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. The patients included 24 males and 19 females with ages ranging from 16 to 85 years. Among them, 10 patients had a parainfectious or septic encephalopathy with delirium.

The paper stated that coronavirus is associated with a wide spectrum of neurological syndromes that affects the whole neuraxis, including the cerebral vasculature and in some cases, responding to immunotherapies. However, this complication is not related to the severity of the disease.

Commenting on the matter, senior author on the study Michael Zandi said: “We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses.”

She added, “What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease.”

Chinese researchers launch phase-2 human test for possible coronavirus vaccine

“We want clinicians around the world to be alert to these complications of coronavirus,” she mentioned.

With millions of Covid-19 deaths across the world, scientists race to develop a vaccine to prevent the virus from spreading further. Most of the renowned pharmaceutical companies globally have begun trials, some entering stage 3 trials.

So far, 547,430 people have died of the disease worldwide while 11,984,936 have been infected. Besides, 58,246 patients are in critical condition while 6,929,661 people recovered from the virus. The highest number of patients were reported in United States with 3,097,538 cases followed by Brazil with 1,674,655 infections and India with 746,506 cases.